Embla Medical hf. (0FIW.L)

29,60 +0,35 (+1,20%) Al cierre: 05:53PM BST

Embla Medical hf.

Grjótháls 1-5
Reykjavik
Iceland
354 515 1300
https://www.ossur.com

Sector(es): 
Sector: 
Empleados a tiempo completo: 4000

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Sveinn Solvason	President & CEO	7,46M	N/A	1978
Mr. Ossur Kristinsson	Founder	173,81k	N/A	1943
Ms. Gudny Arna Sveinsdottir	Chief Financial Officer	N/A	N/A	1966
Mr. Lukas Marklin	Chief Operating Officer	N/A	N/A	1974
Edda Lara Luovigsdottir	Investor Relations Director	N/A	N/A	N/A
Ms. Margret Lara Fridriksdottir	Executive Vice President of People, Strategy & Sustainability	1,65M	N/A	1978
Mr. Olafur Gylfason	Chief Commercial Officer	3,75M	N/A	1969
Mr. Gudjon G. Karason	Executive Vice President of EMEA & APAC	N/A	N/A	1969
Mr. Christian Robinson	President of Americas	N/A	N/A	1982
Ms. Hildur Einarsdottir	Executive Vice President of Research & Development	N/A	N/A	1982

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en DKK.

Descripción

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics, Bracing & Supports, and Patient Care. The Prosthetics segment offers mechanical products, such as lower limb prosthetics and finger prostheses; and bionic products microprocessor-controlled feet, knees, hands, liners, fingers, and other components integrated. Its Bracing & Supports segment provides bracing and supports products, such as supporting devices for spinal, hip, knee, foot, ankle, and hands for therapeutic and preventative purposes; and injury solutions for people recovering from fractures and ligament injuries. The Patient Care segment offers prosthetics for people with lower and upper limb loss or limb difference; and orthotics for neurological, gait, and musculoskeletal conditions. It serves specialized healthcare providers, including orthopedic and prosthetic clinics, hospitals, and surgery centers. The company sells its products through its direct sales networks and distributors. The company was formerly known as Össur hf. and changed its name to Embla Medical hf. in April 2024. Embla Medical hf. was incorporated in 1971 and is headquartered in Reykjavik, Iceland. Embla Medical hf. is a subsidiary of William Demant Invest A/S.

Gobierno corporativo

El ISS Governance QualityScore de Embla Medical hf., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.